TREATMENT SET TS350663 injection, solution TREATMENT SET TS350905 injection, solution TREATMENT SET TS350906 injection, soluti

Negara: Amerika Serikat

Bahasa: Inggris

Sumber: NLM (National Library of Medicine)

Bahan aktif:

AMBROSIA ARTEMISIIFOLIA POLLEN (UNII: K20Y81ACO3) (AMBROSIA ARTEMISIIFOLIA POLLEN - UNII:K20Y81ACO3), CYNODON DACTYLON POLLEN (UNII: 175F461W10) (CYNODON DACTYLON POLLEN - UNII:175F461W10), FESTUCA PRATENSIS POLLEN (UNII: A0WFQ8P6N1) (FESTUCA PRATENSIS POLLEN - UNII:A0WFQ8P6N1), PHLEUM PRATENSE POLLEN (UNII: 65M88RW2EG) (PHLEUM PRATENSE POLLEN - UNII:65M88RW2EG), PASCOPYRUM SMITHII POLLEN (UNII: 6AU0ZD8T1O) (PASCOPYRUM SMITHII POLLEN - UNII:6AU0ZD8T1O), CANIS LUPUS FAMILIARIS HAIR (UNII: 05S7L91ZTR) (

Tersedia dari:

Antigen Laboratories, Inc.

Rute administrasi :

SUBCUTANEOUS

Indikasi Terapi:

When the natural exposure to elevated aeroallergens produces symptoms as described under Clinical Pharmacology, specific diagnosis and therapeutic procedures are indicated. Clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. Diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. Specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. When immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. An orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 THIS PRODUCT IS NOT INTENDED FOR TREATMENT OF PATIENTS WHO DO NOT MANIFEST IMMEDIATE HYPERSENSITIVITY REACTIONS TO THE ALLERGENIC EXTRACT FOLLOWING SKIN TESTING. There are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

Ringkasan produk:

Individual treatment sets as prescribed by the physician. The allergenic extract contains a variable number of individual doses depending on the patient's sensitivity and maximum tolerated maintenance treatment dose.

Status otorisasi:

Biologic Licensing Application

Karakteristik produk

TREATMENT SET TS350663 - TREATMENT SET TS350663 INJECTION, SOLUTION
TREATMENT SET TS350905 - TREATMENT SET TS350905 INJECTION, SOLUTION
TREATMENT SET TS350906 - TREATMENT SET TS350906 INJECTION, SOLUTION
TREATMENT SET TS351004 - TREATMENT SET TS351004 INJECTION, SOLUTION
TREATMENT SET TS351003 - TREATMENT SET TS351003 INJECTION, SOLUTION
TREATMENT SET TS351030 - TREATMENT SET TS351030 INJECTION, SOLUTION
TREATMENT SET TS351031 - TREATMENT SET TS351031 INJECTION, SOLUTION
TREATMENT SET TS351125 - TREATMENT SET TS351125 INJECTION, SOLUTION
TREATMENT SET TS351129 - TREATMENT SET TS351129 INJECTION, SOLUTION
TREATMENT SET TS351142 - TREATMENT SET TS351142 INJECTION, SOLUTION
TREATMENT SET TS351167 - TREATMENT SET TS351167 INJECTION, SOLUTION
TREATMENT SET TS351200 - TREATMENT SET TS351200 INJECTION, SOLUTION
TREATMENT SET TS351201 - TREATMENT SET TS351201 INJECTION, SOLUTION
TREATMENT SET TS351312 - TREATMENT SET TS351312 INJECTION, SOLUTION
TREATMENT SET TS351313 - TREATMENT SET TS351313 INJECTION, SOLUTION
TREATMENT SET TS351314 - TREATMENT SET TS351314 INJECTION, SOLUTION
TREATMENT SET TS351315 - TREATMENT SET TS351315 INJECTION, SOLUTION
ANTIGEN LABORATORIES, INC.
----------
ALLERGENIC EXTRACTS
INDIVIDUAL TREATMENT VIAL
WARNINGS
INDIVIDUAL ALLERGENIC EXTRACT TREATMENT VIAL IS INTENDED FOR USE BY
PHYSICIANS WHO ARE
EXPERIENCED IN THE ADMINISTRATION OF ALLERGENIC EXTRACTS FOR
IMMUNOTHERAPY AND THE
EMERGENCY CARE OF ANAPHYLAXIS, OR FOR USE UNDER THE GUIDANCE OF AN
ALLERGY SPECIALIST.
INDIVIDUAL ALLERGENIC EXTRACT TREATMENT VIALS ARE NOT DIRECTLY
INTERCHANGEABLE WITH OTHER
ALLERGENIC EXTRACTS. THE INITIAL DOSE MUST BE BASED ON SKIN TESTING AS
DESCRIBED IN THE
DOSAGE AND ADMINISTRATION SECTION OF THIS INSERT. PATIENTS BEING
SWITCHED FROM OTHER TYPES
OF EXTRACT TO INDIVIDUAL TREATMENT VIALS SHOULD BE STARTED AS THOUGH
THEY WERE COMING UNDER
TREATMENT FOR THE FIRST TIME. PATIENTS SHOULD BE INSTRUCTED TO
RECOGNIZE ADVERSE REACTION
SYMPTOMS AND CAUTIONED TO CONTACT THE PHYSICIAN'S OFFICE IF REACTION
SYMPTOMS OCCUR. AS
WIT